Healthcare is drawing fresh buying as money moves away from the market’s popular technology trade, and one messenger RNA (mRNA) name is pulling well ahead of the pack. Moderna (NASDAQ:MRNA | MRNA ...
1mon
Could a New Vaccine Formula XFG Give Pfizer (PFE) and BioNTech (BNTX) a Post-Pandemic Revenue Boost?
Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) announced on August 27 that the U.S. FDA has approved the supplemental Biologics License Application for their 2026–2027 COVID-19 vaccine formula, ...
European regulators have officially approved the latest 2026–2027 COVID-19 vaccine formula from Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX). Designed to protect against the widespread XFG ...
Profit taking is hitting one of biotech’s hottest trades, and the selling is landing heaviest on the stock that ran the ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Hosted on MSN
BioNTech's next act has nothing to do with COVID. Here's the $500 billion market some investors are ignoring
BioNTech's oncology pipeline could help it make a dent in this large and growing market. However, there is one thing investors should consider before initiating a position. 10 stocks we like better ...
Pfizer and BioNTech's Covid-19 vaccine for the 2026 to 2027 season received approval from the European Commission. The vaccine targets the XFG variant and the companies said that data indicates that ...
BioNTech (BNTX) ADRs lost ~5% in the premarket on Thursday after Bloomberg News reported that Pfizer (PFE) is planning to sell its remaining stake in its partner, which helped the U.S. pharma giant to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results